Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff

Biotech stocks are seeking to regain some semblance of normalcy after Wednesday's Trump-inspired selloff. Much against market perceptions of a biotech-friendly President-elect Donald Trump stance, he hit out at the sector, with a vague message that suggested he is going to clamp down on drug prices.

Biotech investors hardly expected such as statement from a person they believed to be sector-friendly, given his earlier neutral stance as opposed to Hillary Clinton, who had made the fight against price gouging as a major election theme. So, it took them by surprise and a selloff promptly followed on Wednesday. The weakness was so stark that it made CNBC's Brian Sullivan tweet that biotechs/healthcare was the only sector to have been left out of what seemed to be a market-wide rally on Wednesday.

Putting Things In Perspective

iShares NASDAQ Biotechnology Index (ETF) IBB gained 12 percent from its pre-election level to 291.33 on November 14 but has been giving back ground since then. On Wednesday, the ETF fell 2.94 percent despite the Dow Jones Industrial Average (INDEXDJX:.DJI) and the S&P 500 (INDEXSP:.INX) hitting new closing highs.

The NYSE ARCA BIOTECH INDEX BTK, which had a 5.4 per gain thus far and a peak gain percentage of roughly 14 percent post the elections, lost a steeper 3.01 percent.

The SPDR S&P Pharmaceuticals (ETF) XPH was off 2 percent at 38.54 Wednesday following a pre-election peak of 42.05 on November 14.

Weird Wednesday For Biotech Stocks

  • Celgene Corporation CELG lost 4.03 percent before ending down 4.03 percent.
  • Illumina, Inc. ILMN ended down 3.5 percent at $122.02.
  • Incyte Corporation INCY ended down 4.90 percent at $101.96.
  • Mylan NV MYL slipped 3.79 percent to $34.50.
  • Regeneron Pharmaceuticals Inc REGN lost 1.88 percent to $362.01.
  • Vertex Pharmaceuticals Incorporated VRTX was down 3.58 percent at $75.32 at the close.

At Last Check

  • Celgene was down 0.28 percent at $112.34.
  • IBB was down 0.86 percent at $263.98.
  • Illumina was down 0.44 percent at $121.48.
  • Mylan was down 0.32 percent at $34.61.
  • Regeneron was up 0.7 percent at $364.55.
  • SPDR S&P Biotech (ETF) XBI was down 1.33 percent at $60.97.
  • Vertex Pharma was down 0.29 percent at $74.10.
  • XPH was down 2.05 percent at $37.75.

Image Credit: By Gage Skidmore from Peoria, AZ, United States of America (Donald Trump) [CC BY-SA 2.0], via Wikimedia Commons

Posted In: BiotechNewsSector ETFsHealth CarePoliticsMoversTrading IdeasETFsGeneralBiotechBrian SullivanDonald Trump
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...